Annual report
4582.TEDINET S100QFOG
Period2022-01-01 → 2022-12-31
Filed2023-03-23
StandardJapan GAAP
ConsolidatedYes
Data checks17 of 17 passed
Amended by S100QG6E (2023-03-24).
Key figures · 100
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥10.0bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales |
| Operating income | ¥2.0bn | 2022-01-01 → 2022-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.0bn | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.1bn | 2022-01-01 → 2022-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.2bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss |
| Total assets | ¥10.4bn | at 2022-12-31 | Cons. | Assets |
| Total liabilities | ¥1.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥8.5bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2021-12-31 | Cons. | Net assets |
| Cash and deposits | ¥6.3bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.3bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.6bn | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥47m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥628m | 2022-01-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥30.2 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.77 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥204.83 | at 2022-12-31 | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 77.6% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.6% | 2022-01-01 → 2022-12-31 | Cons. | Rate of return on equity (5-year summary) |
| Employees | 122 | at 2022-12-31 | Cons. | Number of employees |
| Revenue | ¥10.0bn | 2022-01-01 → 2022-12-31 | Standalone | Net sales |
| Revenue | ¥8.3bn | 2021-01-01 → 2021-12-31 | Standalone | Net sales |
| Revenue | ¥3.0bn | 2020-01-01 → 2020-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥2.8bn | 2019-01-01 → 2019-12-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥3.8bn | 2018-01-01 → 2018-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.0bn | 2022-01-01 → 2022-12-31 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2021-01-01 → 2021-12-31 | Standalone | Operating income |
| Ordinary income | ¥2.0bn | 2022-01-01 → 2022-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-01-01 → 2021-12-31 | Standalone | Ordinary income |
| Ordinary income | −¥4.6bn | 2020-01-01 → 2020-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥4.4bn | 2019-01-01 → 2019-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥2.7bn | 2018-01-01 → 2018-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.1bn | 2022-01-01 → 2022-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.0bn | 2021-01-01 → 2021-12-31 | Standalone | Income before income taxes |
| Net income | ¥1.2bn | 2022-01-01 → 2022-12-31 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2021-01-01 → 2021-12-31 | Standalone | Profit loss |
| Net income | −¥4.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥4.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥2.8bn | 2018-01-01 → 2018-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥10.4bn | at 2022-12-31 | Standalone | Assets |
| Total assets | ¥8.5bn | at 2021-12-31 | Standalone | Assets |
| Total assets | ¥6.3bn | at 2020-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥5.3bn | at 2019-12-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥6.2bn | at 2018-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.9bn | at 2022-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.7bn | at 2021-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥8.5bn | at 2022-12-31 | Standalone | Net assets |
| Net assets / equity | ¥6.7bn | at 2021-12-31 | Standalone | Net assets |
| Net assets / equity | ¥4.7bn | at 2020-12-31d | Standalone | Net assets |
| Net assets / equity | ¥4.4bn | at 2019-12-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.9bn | at 2018-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2022-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥3.9bn | at 2021-12-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥3.9bn | at 2021-12-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.8bn | at 2020-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥3.9bn | at 2019-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.8bn | at 2018-12-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥140m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥4.1bn | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥4.4bn | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.3bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥71m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥160m | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥216m | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26m | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥72m | 2021-01-01 → 2021-12-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.2bn | 2020-01-01 → 2020-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.7bn | 2019-01-01 → 2019-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥4.3bn | 2018-01-01 → 2018-12-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥30.37 | 2022-01-01 → 2022-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.04 | 2021-01-01 → 2021-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-124.13 | 2020-01-01 → 2020-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-189.03 | 2019-01-01 → 2019-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-165.54 | 2018-01-01 → 2018-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥29.95 | 2022-01-01 → 2022-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.32 | 2021-01-01 → 2021-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥204.95 | at 2022-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥162.26 | at 2021-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥105.76 | at 2020-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥143.07 | at 2019-12-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥212.23 | at 2018-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 77.8% | at 2022-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2021-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.3% | at 2020-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.7% | at 2019-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.1% | at 2018-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.6% | 2022-01-01 → 2022-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 39.6% | 2021-01-01 → 2021-12-31 | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 39,603,606 | at 2022-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 38,457,206 | at 2021-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 38,202,956 | at 2020-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 26,437,681 | at 2019-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 83,398,924 | at 2018-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 118 | at 2022-12-31 | Standalone | Number of employees |
| Employees | 141 | at 2021-12-31 | Standalone | Number of employees |
| Employees | 127 | at 2020-12-31d | Standalone | Number of employees |
| Employees | 107 | at 2019-12-31d | Standalone | Number of employees |
| Employees | 90 | at 2018-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 1
| Segment | Item | Period | Value |
|---|---|---|---|
| Research And Development Manufacturing And Sales Of Pharmaceuticals Etc And Related Businessreportable segment | employees | at 2022-12-31 | 122 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,061
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number nearest place of contact cover page | FilingDateInstant | 03(5472)1125 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務経理部長 畔栁 隆次 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E24682 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 45820 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)シンバイオ製薬株式会社 | |
| Filer name in english | FilingDateInstant | SymBio Pharmaceuticals Limited | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | cte | |
| Current fiscal year start date | FilingDateInstant | 2022-01-01 | |
| Current period end date | FilingDateInstant | 2022-12-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2022-12-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-01-01 | |
| Comparative period end date | FilingDateInstant | 2021-12-31 | |
| Previous fiscal year end date | FilingDateInstant | 2021-12-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所グロース | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)完全議決権株式であり、権利内容に何ら限定のない当社における標準となる株式であります。単元株式数は、100株であります。 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 17 of 17 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |